News
Wanbang Pharmaceutical Conducts Comprehensive Pre-Holiday Safety Inspection
Date:
01 Mar,2021
From January 25 to 26, 2013, Wanbang Pharmaceutical conducted a comprehensive safety inspection across all workshops, departments, the Shangma Plant Area, and employee dormitories. Inspection team members rigorously reviewed each site—such as the boiler room, injection production facility, and laboratory—against the provisions outlined in the company’s Document No. 5, "Opinions on Safe Production." Identified weaknesses and potential safety hazards were immediately addressed with the issuance of "Hazards Rectification Notices," mandating that responsible departments complete corrective actions within a specified timeframe. Following the inspection, the team compiled and discussed the findings, then shared the results with relevant stakeholders.
The photo shows the status of the comprehensive safety inspection.
Related Recommendations